Alumni Ventures

Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), a novel imaging modality that detects iron oxide nanoparticle tracers using time-varying magnetic fields. The company has developed several key products, including the MOMENTUM imager, a pre-clinical MPI solution that produces detailed images through advanced reconstruction techniques, and VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies. Additionally, the company offers Hyper, a module for localized magnetic hyperthermia, and Relax, which focuses on particle relaxometry. Founded in 2012 and based in Alameda, California, Magnetic Insight is dedicated to enhancing preclinical diagnostics and research by enabling quantitative cell tracking, imaging vascular functions, and detecting metastatic tumors, thereby addressing significant challenges in clinical and translational research.

Finwave Semiconductor specializes in the development of advanced gallium nitride (GaN) transistors and integrated circuits (ICs) tailored for 5G communications and power conversion applications. The company utilizes a unique 3DGaN technology, specifically its differentiated fin field-effect transistor (FinFET) design, to enhance the performance of high-volume applications such as radio frequency front end (RFFE) systems for mobile devices. This innovative approach allows Finwave to create semiconductor materials with distinct properties, contributing to advancements in electronics and energy management.

Nextiles is a New York-based company founded in 2019 that specializes in smart apparel technology, merging athletic clothing with an advanced analytics system to enhance exercise performance and safety. The company innovatively integrates electrically conductive fibers into fabrics using a patented sewing technology, allowing for the development of wearables that include motion sensors directly within the apparel. This unique approach enables the creation of responsive and adaptive devices, providing valuable insights into an individual's movement patterns. With a strong foundation in electrical engineering and circuit design, Nextiles offers its expertise to businesses looking to develop or enhance their own Internet of Things (IoT) and smart device products.

NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care.

Syntiant is moving artificial intelligence and machine learning from the cloud to edge devices. Syntiant’s advanced chip solutions merge deep learning with semiconductor design to produce ultra-low-power, high performance, deep neural network processors for always-on applications in battery-powered devices, such as smartphones, smart speakers, earbuds, hearing aids, and laptops. It was founded in 2017 and is headquartered in Irvine, California.

Developer of photonics computing chips designed to handle workloads necessary for the artificial intelligence industry. The company's product is an AI training and inference chip that can fit in itself the computing power of supercomputers, enabling organizations to solve the major bottlenecks in communication.

Epicore Biosystems, Inc. has developed a proprietary wearable microfluidic platform that is ‘skin-like’ and capable of analyzing small droplets of sweat for proteomics, inflammatory markers, hydration, and health biomarkers to enable personalized management of health, performance and nutrition. Epicore's wearable sensing technology is based on over two decades of microfluidics and soft materials research by Prof. John Rogers and Prof. Roozbeh Ghaffari at Northwestern University's Querrey-Simpson Institute for Biolectronics.

Droplette Inc., established in 2017 and based in Boston, Massachusetts, specializes in the development of a needle-free skincare device that utilizes a patent-pending transdermal delivery system. This innovative technology allows for the delivery of ingredients under the skin's surface, reaching depths suitable for larger molecules than traditional methods. The device is designed to be painless, portable, and environmentally friendly, generating no disposables. It has applications in delivering antibiotics for serious ulcers and skin infections, thereby reducing the risk of complications and antibiotic resistance. Future uses may include targeted delivery of chemotherapeutics for skin cancer and other therapeutic agents aimed at anti-aging. Through its scientific advancements, Droplette aims to enhance skin health while providing a safer alternative to conventional skincare treatments.

Sepion is an advanced membrane company offering a platform suite of highly-tunable nanoscale membranes for multiple industrial markets.

Point One Navigation is building a localization service accurate down to a few centimeters at a cost 100x less than existing solutions. Using proprietary sensor fusion algorithms between computer vision and satellite navigation data coupled with a network of sensors, the solution out performs inferior single sensor techniques and does so without the need for special hardware. More info available at info@pointonenav.com

Developer of a cancer treatment system designed to simplify cancer radiation therapy. The company's system is integrated with a radiotherapy machine specializing in 3D image capturing, controlling radiation beams, and automatically delivering the right amount of energy to the right tissue, enabling patients to access and connect with a centralized cancer care center for cancer radiation therapies and reduce the pain and cost of chemo and radiation therapy.

Cyrus Biotechnology builds software tools to accelerate basic research in biotech, pharma, and industrial biotechnology. Cyrus Bench delivers an enterprise version of the Rosetta molecular modeling and design toolkit, with the associated array of bio-molecular computation tools. It was founded in 2014 and headquartered in Seattle, Washington.

SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.

InteRNA Technologies B.V. is a biotechnology company based in Nijmegen, the Netherlands, with a research and development center in Utrecht. Founded in 2006, the company focuses on developing microRNA (miRNA)-based therapeutics aimed at treating cancer. These drugs target previously undruggable pathways, enhancing the effectiveness of existing therapies and addressing drug resistance. InteRNA employs advanced techniques such as massively parallel sequencing and proprietary bioinformatics to analyze and validate miRNA sequences. Recently, the company secured additional equity financing to further advance its lead program for melanoma treatment, reflecting its commitment to innovation in oncology.

Nitricity is an energy company focused on developing a system for producing carbon-free fertilizer. Utilizing its innovative technology, the company generates ready-to-use nitrogen from air, water, and renewable electricity. Nitricity produces both nitric acid and ammonia, which can be utilized individually or combined to create ammonium nitrate fertilizer. This approach aims to provide farmers with effective products that minimize wasteful runoff, allow for precise application timing, and enhance nitrogen delivery globally. Through its sustainable practices, Nitricity seeks to support agricultural efficiency and environmental stewardship.

Diamond Age automates the construction of single-family homes and makes the American Dream affordable. It is based in Pleasanton, CA, USA.

NeuReality is a semiconductor start-up that designs AI-as-a-service infrastructure. It addresses the challenges posed by the growing deployment of AI in the cloud, edge, and fog systems.

SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.

Glympse Bio, Inc. is focused on developing innovative diagnostic solutions that facilitate noninvasive monitoring of various diseases, including cancer, fibrosis, immunological disorders, and infectious diseases. The company employs modular nanoparticle sensors, utilizing precisely engineered diagnostic agents that assess disease states within the body and convey this information through urine analysis. This approach allows for predictive monitoring and evaluation of treatment responses. Founded in 2015 and based in Cambridge, Massachusetts, Glympse Bio's technology is rooted in research originally conducted at MIT and led by a team of experts in nanomedicine and biomedical engineering. Their flagship product, Glympse Inside, serves as a comprehensive platform for disease monitoring and aims to revolutionize how diseases are diagnosed and managed.

Emulate, Inc. specializes in developing organs-on-chips technology that emulates human biology to better understand the effects of diseases, medications, and environmental factors on human health. The company offers organ-chips that replicate the functions of various organs, including the lung, intestine, liver, and skin, and can simulate both normal and disease states. Emulate’s platform aims to provide more accurate predictions of human responses compared to traditional experimental methods, such as cell cultures or animal testing. The company serves a diverse clientele that includes biotechnology and pharmaceutical firms, consumer health and cosmetics companies, government agencies, and academic researchers. Founded in 2013 and based in Boston, Massachusetts, Emulate was previously known as Emulate Living MicroDevices, Inc. It has shifted its focus towards advancing product innovation and safety across multiple sectors, including drug development and personalized medicine.

Emulate, Inc. specializes in developing organs-on-chips technology that emulates human biology to better understand the effects of diseases, medications, and environmental factors on human health. The company offers organ-chips that replicate the functions of various organs, including the lung, intestine, liver, and skin, and can simulate both normal and disease states. Emulate’s platform aims to provide more accurate predictions of human responses compared to traditional experimental methods, such as cell cultures or animal testing. The company serves a diverse clientele that includes biotechnology and pharmaceutical firms, consumer health and cosmetics companies, government agencies, and academic researchers. Founded in 2013 and based in Boston, Massachusetts, Emulate was previously known as Emulate Living MicroDevices, Inc. It has shifted its focus towards advancing product innovation and safety across multiple sectors, including drug development and personalized medicine.

Inchfab specializes in custom microchip manufacturing, offering proprietary tools that cater to the microelectromechanical systems (MEMS) market. The company's microfabrication platform enables clients to prototype and produce low volumes of highly customized microchips economically. By focusing on the semiconductor and micromechanical Internet of Things (IoT) chip markets, Inchfab provides essential manufacturing capabilities that facilitate the design and production of specialized devices.

Notable Labs, Inc. develops and operates a platform that provides lab testing services for brain cancer patients. The company runs drug combination experiments on the tumor and gives a report back to the patient’s doctor. Notable Labs, Inc. was formerly known as StemCycle, Inc. The company was incorporated in 2014 and is based in Foster City, California.

Vincere Biosciences Inc is a biotechnology company based in Cambridge, Massachusetts, focused on developing small molecule therapeutics aimed at halting the progression of Parkinson's disease. Founded in 2018, the company utilizes proprietary simulation and artificial intelligence to transform discoveries into effective therapeutic programs. Its patented biology simulation technology integrates extensive human genomic and biochemical data, facilitating research and clinical studies. This innovative approach aims to restore mitochondrial quality and offers a pathway for medical researchers to access potential treatments for Parkinson's disease, enhancing the development of drugs designed to alleviate its impact. As a JLABS incubator company, Vincere is positioned at the forefront of neurodegenerative disease research.

NuCurrent, Inc. specializes in the design, fabrication, and integration of advanced wireless power antennas, surface-mount inductors, and inductive coils. The company develops high-efficiency antennas that comply with various industry standards, including those set by the Alliance for Wireless Power, the Wireless Power Consortium, and the Power Matters Alliance. NuCurrent collaborates closely with original equipment manufacturers and integrators to create custom-designed and rapidly prototyped solutions tailored for a wide array of applications. Its patented designs and manufacturing techniques enhance performance by addressing common high-frequency challenges, resulting in antennas that are more efficient, compact, durable, and cost-effective. Founded in 2009, NuCurrent is headquartered in Chicago, Illinois.

NuCurrent, Inc. specializes in the design, fabrication, and integration of advanced wireless power antennas, surface-mount inductors, and inductive coils. The company develops high-efficiency antennas that comply with various industry standards, including those set by the Alliance for Wireless Power, the Wireless Power Consortium, and the Power Matters Alliance. NuCurrent collaborates closely with original equipment manufacturers and integrators to create custom-designed and rapidly prototyped solutions tailored for a wide array of applications. Its patented designs and manufacturing techniques enhance performance by addressing common high-frequency challenges, resulting in antennas that are more efficient, compact, durable, and cost-effective. Founded in 2009, NuCurrent is headquartered in Chicago, Illinois.

StemoniX Inc. is a biotechnology company that specializes in stem cell technologies to enhance drug discovery and personalized medicine. Founded in 2014 and headquartered in Minneapolis, Minnesota, with an additional office in La Jolla, California, StemoniX provides innovative platforms for pharmaceutical and research institutions. Its flagship solution focuses on the three-dimensional printing of stem-cell-derived human tissue, enabling the creation of living cells in larger formats. This technology is particularly beneficial for studying various diseases, including heart disease, dementia, breast cancer, autism, and ALS. By advancing the production and application of stem cell technologies, StemoniX aims to meet the evolving needs of the healthcare sector.

Neuspera Medical Inc. specializes in the development and manufacture of ultra-miniaturized implantable devices designed for neuromodulation therapy, often referred to as "electroceuticals." Utilizing licensed mid-field powering technology, these devices leverage the body as a natural waveguide to deliver energy effectively. Founded in 2013 and based in San Jose, California, Neuspera aims to enhance the quality of life for patients dealing with chronic illnesses by providing less invasive and adaptable treatment options. The company's innovative approach allows for deeper implantation of its devices, offering patients new possibilities in managing their health conditions.

SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.

Neuspera Medical Inc. specializes in the development and manufacture of ultra-miniaturized implantable devices designed for neuromodulation therapy, often referred to as "electroceuticals." Utilizing licensed mid-field powering technology, these devices leverage the body as a natural waveguide to deliver energy effectively. Founded in 2013 and based in San Jose, California, Neuspera aims to enhance the quality of life for patients dealing with chronic illnesses by providing less invasive and adaptable treatment options. The company's innovative approach allows for deeper implantation of its devices, offering patients new possibilities in managing their health conditions.

Manus Bio Inc. recreates plant processes in microorganisms to produce natural ingredients through fermentation. The company’s microbial platform converts sugar sources into ingredients with applications, such as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals, and agricultural chemicals. It merges metabolic engineering, protein engineering, and systems biology technologies to generate microbes that produce various plant-based ingredients. The company has a strategic partnership with BBGI Public Company Limited. Manus Bio Inc. was formerly known as Manus Biosynthesis, Inc. and changed its name to Manus Bio Inc. in June 2018. The company was founded in 2011 and is based in Cambridge, Massachusetts. It has manufacturing facilities in Cambridge, Massachusetts; and Augusta, Georgia.

RayVio Corp. is an advanced health and hygiene company that delivers clean water and environments. RayVio helps protect billions from germs and creates new markets and revenue streams by enabling a new class of products. Its powerful and efficient UV LED technology can be integrated into a variety of applications, powering versatile on-demand solutions that give consumers control over health without chemicals or costly consumables. To learn more, please visit www.rayvio.com.

Exicure, Inc. is a clinical-stage biotechnology company based in Chicago, Illinois, that focuses on developing therapeutics utilizing its proprietary spherical nucleic acid (SNA) technology. The company is engaged in creating innovative immunomodulatory and gene silencing drugs aimed at treating neurological disorders, immuno-oncology, inflammatory diseases, and genetic conditions. Its lead drug candidate, AST-008, is currently undergoing Phase 1b/2 clinical trials for advanced solid tumors. Additionally, Exicure is advancing XCUR-FXN, an SNA-based therapeutic in preclinical trials for Friedreich’s ataxia, and XCUR17, which targets interleukin 17 receptor alpha mRNA. Exicure has entered into collaborations with Allergan Pharmaceuticals to develop treatments for hair loss and with DERMELIX to research and commercialize therapies for Netherton syndrome. The company was founded in 2011 and aims to overcome delivery challenges associated with nucleic acid therapeutics through its unique SNA constructs.

Consumer Physics Inc., based in Tel Aviv, Israel, specializes in the development and distribution of molecular sensors under the SCiO brand. Since its incorporation in 2011, the company has focused on empowering consumers and businesses to analyze the composition of materials using its compact near-infrared spectrometer. The SCiO device connects to smartphone applications and a cloud-based database of material fingerprints, allowing users to access real-time material analysis. Additionally, Consumer Physics provides a platform for businesses and third-party developers to create customized molecular sensing models and mobile applications, facilitating data-driven decisions that can help reduce food waste and enhance operational efficiency in industries such as food and agriculture. The SCiO DevKit offers developers the necessary tools and support to innovate in this area.

Manus Bio Inc. recreates plant processes in microorganisms to produce natural ingredients through fermentation. The company’s microbial platform converts sugar sources into ingredients with applications, such as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals, and agricultural chemicals. It merges metabolic engineering, protein engineering, and systems biology technologies to generate microbes that produce various plant-based ingredients. The company has a strategic partnership with BBGI Public Company Limited. Manus Bio Inc. was formerly known as Manus Biosynthesis, Inc. and changed its name to Manus Bio Inc. in June 2018. The company was founded in 2011 and is based in Cambridge, Massachusetts. It has manufacturing facilities in Cambridge, Massachusetts; and Augusta, Georgia.

NuCurrent, Inc. specializes in the design, fabrication, and integration of advanced wireless power antennas, surface-mount inductors, and inductive coils. The company develops high-efficiency antennas that comply with various industry standards, including those set by the Alliance for Wireless Power, the Wireless Power Consortium, and the Power Matters Alliance. NuCurrent collaborates closely with original equipment manufacturers and integrators to create custom-designed and rapidly prototyped solutions tailored for a wide array of applications. Its patented designs and manufacturing techniques enhance performance by addressing common high-frequency challenges, resulting in antennas that are more efficient, compact, durable, and cost-effective. Founded in 2009, NuCurrent is headquartered in Chicago, Illinois.